DPHARMA

Second Interim Dividend (with Dividend Re-Investment Plan)

DUOPHARMA BIOTECH BERHAD

Entitlement subject Second Interim Dividend (with Dividend Re-Investment Plan)
Entitlement description
Second interim dividend of RM0.06 per ordinary share
Ex-Date 21 Apr 2021
Entitlement date 22 Apr 2021
Entitlement time 5:00 PM
Financial Year End 31 Dec 2020
Share transfer book & register of members will be  to  closed from (both dates inclusive) for the purpose of determining the entitlement
Payment Date 21 May 2021
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers 22 Apr 2021
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units)
(If applicable)
Entitlement indicator Currency
Entitlement in Currency Malaysian Ringgit (MYR)  0.0600
Options Available to Shareholders Cash or Securities

Cash

Cash^ Entitlement

1
Tax Indicator Tax Exempt / Non-taxable
Currency Malaysian Ringgit (MYR)
Amount 0.0600

or Securities

Re-invest Cash Entitlement into Securities
Entitlement Malaysian Ringgit (MYR)  0.0600
Company Name
DUOPHARMA BIOTECH BERHAD
Issue Price per Unit Malaysian Ringgit (MYR) 3.0800
Deadline To Respond 10 May 2021 05:00 PM
Securities Crediting Date 21 May 2021
Available/Listing Date 24 May 2021
Fractional Entitlement Cash in Lieu of Fraction
Malaysian Ringgit (MYR) 3.0800 per unit
Note: You will receive Cash^ if you do not Re-invest.

Registrar or Service Provider name, address, telephone no TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD
Unit 32-01, Level 32, Tower A,
Vertical Business Suite, Avenue 3, Bangsar South,

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Wilayah Persekutuan

Malaysia

Tel:0327839299
Fax:0327839222


Remarks :
The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company") ("Board") has declared a single-tier second interim dividend of RM0.06 per ordinary share in Duopharma Biotech ("Duopharma Biotech Shares") in respect of the financial year ended 31 December 2020. The Board has also determined the dividend reinvestment plan ("DRP") would apply to the second interim dividend.

Following the above, on behalf of the Board, Mercury Securities Sdn Bhd had on 22 February 2021 announced that the issue price of the new Duopharma Biotech Shares to be issued pursuant to the DRP has been fixed at RM3.08 per Duopharma Biotech Share.

This announcement is dated 8 April 2021.


Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 08 Apr 2021
Category Entitlement(Notice of Book Closure)
Reference Number ENT-06042021-00006
Corporate Action ID MY210406DRIP0002


View original